Literature DB >> 17189480

The SH3 domain of a M7 interacts with its C-terminal proline-rich region.

Qinghua Wang1, Matthew A Deloia, Yang Kang, Casey Litchke, Naixia Zhang, Margaret A Titus, Kylie J Walters.   

Abstract

Myosins play essential roles in migration, cytokinesis, endocytosis, and adhesion. They are composed of a large N-terminal motor domain with ATPase and actin binding sites and C-terminal neck and tail regions, whose functional roles and structural context in the protein are less well characterized. The tail regions of myosins I, IV, VII, XII, and XV each contain a putative SH3 domain that may be involved in protein-protein interactions. SH3 domains are reported to bind proline-rich motifs, especially "PxxP" sequences, and such interactions serve regulatory functions. The activity of Src, PI3, and Itk kinases, for example, is regulated by intramolecular interactions between their SH3 domain and internal proline-rich sequences. Here, we use NMR spectroscopy to reveal the structure of a protein construct from Dictyostelium myosin VII (DdM7) spanning A1620-T1706, which contains its SH3 domain and adjacent proline-rich region. The SH3 domain forms the signature beta-barrel architecture found in other SH3 domains, with conserved tryptophan and tyrosine residues forming a hydrophobic pocket known to bind "PxxP" motifs. In addition, acidic residues in the RT or n-Src loops are available to interact with the basic anchoring residues that are typically found in ligands or proteins that bind SH3 domains. The DdM7 SH3 differs in the hydrophobicity of the second pocket formed by the 3(10) helix and following beta-strand, which contains polar rather than hydrophobic side chains. Most unusual, however, is that this domain binds its adjacent proline-rich region at a surface remote from the region previously identified to bind "PxxP" motifs. The interaction may affect the orientation of the tail without sacrificing the availability of the canonical "PxxP"-binding surface.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17189480      PMCID: PMC2203285          DOI: 10.1110/ps.062496807

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  30 in total

1.  Solution structure of the SH3 domain of Src and identification of its ligand-binding site.

Authors:  H Yu; M K Rosen; T B Shin; C Seidel-Dugan; J S Brugge; S L Schreiber
Journal:  Science       Date:  1992-12-04       Impact factor: 47.728

Review 2.  Promiscuous binding nature of SH3 domains to their target proteins.

Authors:  Vishal Agrawal; K V Radha Kishan
Journal:  Protein Pept Lett       Date:  2002-06       Impact factor: 1.890

3.  Crystal structure of a Src-homology 3 (SH3) domain.

Authors:  A Musacchio; M Noble; R Pauptit; R Wierenga; M Saraste
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

4.  Crystal structure of the SH3 domain in human Fyn; comparison of the three-dimensional structures of SH3 domains in tyrosine kinases and spectrin.

Authors:  M E Noble; A Musacchio; M Saraste; S A Courtneidge; R K Wierenga
Journal:  EMBO J       Date:  1993-07       Impact factor: 11.598

5.  The program XEASY for computer-supported NMR spectral analysis of biological macromolecules.

Authors:  C Bartels; T H Xia; M Billeter; P Güntert; K Wüthrich
Journal:  J Biomol NMR       Date:  1995-07       Impact factor: 2.835

6.  Sequential assignment of proline-rich regions in proteins: application to modular binding domain complexes.

Authors:  V Kanelis; L Donaldson; D R Muhandiram; D Rotin; J D Forman-Kay; L E Kay
Journal:  J Biomol NMR       Date:  2000-03       Impact factor: 2.835

7.  Protein backbone angle restraints from searching a database for chemical shift and sequence homology.

Authors:  G Cornilescu; F Delaglio; A Bax
Journal:  J Biomol NMR       Date:  1999-03       Impact factor: 2.835

8.  Organization and ligand binding properties of the tail of Acanthamoeba myosin-IA. Identification of an actin-binding site in the basic (tail homology-1) domain.

Authors:  W L Lee; E M Ostap; H G Zot; T D Pollard
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

9.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

10.  A role for myosin VII in dynamic cell adhesion.

Authors:  R I Tuxworth; I Weber; D Wessels; G C Addicks; D R Soll; G Gerisch; M A Titus
Journal:  Curr Biol       Date:  2001-03-06       Impact factor: 10.834

View more
  6 in total

Review 1.  SH3 domains: modules of protein-protein interactions.

Authors:  Natalya Kurochkina; Udayan Guha
Journal:  Biophys Rev       Date:  2012-06-20

2.  Homology modeling and global computational mutagenesis of human myosin VIIa.

Authors:  Annapurna Kuppa; Yuri V Sergeev
Journal:  J Anal Pharm Res       Date:  2021-03-04

3.  PeptideMine--a webserver for the design of peptides for protein-peptide binding studies derived from protein-protein interactomes.

Authors:  Khader Shameer; Lalima L Madan; Shivamurthy Veeranna; Balasubramanian Gopal; Ramanathan Sowdhamini
Journal:  BMC Bioinformatics       Date:  2010-09-22       Impact factor: 3.169

4.  Evidence for an interaction between the SH3 domain and the N-terminal extension of the essential light chain in class II myosins.

Authors:  Susan Lowey; Lakshmi D Saraswat; HongJun Liu; Niels Volkmann; Dorit Hanein
Journal:  J Mol Biol       Date:  2007-06-02       Impact factor: 5.469

5.  Identification of self-regulatory network motifs in reverse engineering gene regulatory networks using microarray gene expression data.

Authors:  Mehrosh Khalid; Sharifullah Khan; Jamil Ahmad; Muhammad Shaheryar
Journal:  IET Syst Biol       Date:  2019-04       Impact factor: 1.615

6.  Exploring Molecular Contacts of MUC1 at CIN85 Binding Interface to Address Future Drug Design Efforts.

Authors:  Maria Rita Gulotta; Serena Vittorio; Rosaria Gitto; Ugo Perricone; Laura De Luca
Journal:  Int J Mol Sci       Date:  2021-02-23       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.